Pharmacokinetics of sparfloxacin and serum bactericidal activity against pneumococci.
Sparfloxacin, a new fluorinated quinolone, exhibits higher in vitro activity against pneumococci than do ciprofloxacin and ofloxacin. Since up to 30% of cases of pneumococcal pneumonia are associated with bacteremia, and since an increasing percentage of pneumococci are resistant against penicillin,...
Saved in:
| Published in: | Antimicrob Agents Chemother |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society for Microbiology (ASM)
1996
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163197/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8851610/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.3.776 |
| Tags: |
No Tags, Be the first to tag this record!
|